about
Kawasaki syndromeMedium-size-vessel vasculitisRelationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki diseaseCurrent perspectives on Kawasaki diseaseUpdate on the treatment of Kawasaki disease in childhoodThe effect of TNFalpha blockade in complicated, refractory Kawasaki diseaseThe diagnosis and management of Kawasaki diseaseDiffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosaNoninvasive determination of endothelial cell function in the microcirculation in Kawasaki syndromeOxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness.Vascular function long term after Kawasaki disease: another piece of the puzzle?Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki diseaseVasculitis--diagnosis and treatment.When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.Kawasaki disease: an update.Recognition and management of Kawasaki disease.Long-term cardiac sequelae of Kawasaki disease.Vascular health late after Kawasaki disease: implications for accelerated atherosclerosis.Does Vitamin C improve endothelial function in patients with Kawasaki disease?Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmasLong term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and functionEndothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis.Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity.Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease.Peripheral Endothelial (Dys)Function, Arterial Stiffness and Carotid Intima-Media Thickness in Patients after Kawasaki Disease: A Systematic Review and Meta-Analyses.Kawasaki disease in the adult: a case report and review of the literature.Risk factors for coronary heart disease in connective tissue diseasesCardiovascular status after Kawasaki disease in the UK.Endothelial function and inflammation in coronary artery disease.Association of cytokines with endothelium dependent flow mediated vasodilation (FMD) of systemic arteries in patients with non-ischemic cardiomyopathy.What's new in the aetiopathogenesis of vasculitis?Correlation of epicardial and systemic flow-mediated vasodilation in patients with atypical angina but no evidence of atherosclerotic disease.Noninvasive cardiac imaging: implications for risk assessment in adolescents and young adults.The outcome of short-term low-dose aspirin treatment in Kawasaki disease based on inflammatory markers.Endothelial function in pre-pubertal children at risk of developing cardiomyopathy: a new frontier.Kawasaki disease and coronary artery aneurysms: from childhood to adulthood.Kawasaki disease and cardiovascular risk: a comprehensive review of subclinical vascular changes in the longer term.Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression.Cardiovascular involvement in Kawaski Disease.Recognizing Kawasaki disease.
P2860
Q24550744-B3F6A66F-3CBD-4CA9-BF96-62BDC45DFEC7Q24604335-B3B079C2-C005-42AA-BFF3-15B4407E1B0CQ24675119-3303A92D-3123-495D-B8B5-93973CD860BFQ28185961-A4126B75-7C4E-4FFE-9F78-069808B150F0Q28194172-F06A742B-1E4C-44E4-81D7-9D141043B780Q28199924-29A951E6-695E-44F2-8D4F-0FA2F5956705Q28211402-2A3BE569-B91C-4791-A318-5818D97F3809Q30881300-B3A58B05-20F3-4CC9-8492-0B3C84456E4DQ33300097-D784C745-485A-423E-AED7-1E6728A3E346Q33333142-780EF376-D819-4C02-965D-30434E43BA2BQ33365295-0C9F3BEE-AD8B-475D-A0CB-418DEB5E1406Q33738998-825A1D16-6033-46B5-9D24-59D607586C6AQ33814342-2EFE9F56-C156-4F6B-BC8A-DE3B4F8C57B1Q33851902-41149E97-2DF2-4061-9509-4306D068D2EFQ33894980-9CEA54A5-9605-4D18-883F-2131CD5520C2Q34034709-5354D7A1-F92A-4C65-A856-80B9D48D7E32Q34109017-C0019585-AFAD-438F-9176-A2995D1875B1Q34785263-28E64119-E163-40D2-A175-A2260AEB30C1Q35160504-E31F00F0-9D3E-4941-B9EC-F98A00A4F40BQ35184950-87C91AB6-3599-4BA4-84DA-CEC97D94B6A7Q35375079-6685B9A0-3960-4061-AB32-828EF56D1336Q35552153-C6D8181B-F3C9-444A-A5C7-7709883B410DQ35553196-E6035D16-22CD-497C-B6DC-C29CC489F8A4Q35583092-B656EFB8-C85A-45DE-AF47-919CA6973808Q35688049-90205919-5E20-414F-8F8A-6F16BB462A71Q35814101-EC061B0A-A190-46B1-B725-2487E9E37DDFQ36056947-F0FCE7E5-39D5-4152-BD24-1D72A7AA0485Q36209060-F7DD8F4A-A6CF-47BA-A128-D57C1872228DQ36256278-5F48B0D7-45EC-477B-BB3A-A9B07E06388FQ36439997-A50AFEBB-39CB-4D6B-8B27-2E682F70348CQ36759362-81686866-327B-41D0-A071-4D221A2D64ACQ37119070-7A6CEB87-4DAD-49D7-9E6F-6F8A9CBF9CB2Q37280883-1BD63BC6-0F40-4630-8560-2D5BC7CD35C7Q37642234-817D0C91-9889-4A67-AE66-3E03BF2DB2C5Q37999685-277A6510-A419-4056-A49C-A4BB4F32C269Q38638912-EC0C52C7-3B30-48F1-BE63-AD13C7C3270EQ38734917-AFE8020B-FCBD-4A79-BEB4-286EA489BC18Q39512381-328519D9-6EA4-4436-BEBD-A43B639038B3Q39654279-E451D7B4-E43F-4CD5-8BA0-3A6503BE3EA1Q40593999-2256D630-7B4C-4613-A481-19F11A5D2A66
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Endothelial dysfunction late after Kawasaki disease.
@ast
Endothelial dysfunction late after Kawasaki disease.
@en
Endothelial dysfunction late after Kawasaki disease.
@nl
type
label
Endothelial dysfunction late after Kawasaki disease.
@ast
Endothelial dysfunction late after Kawasaki disease.
@en
Endothelial dysfunction late after Kawasaki disease.
@nl
prefLabel
Endothelial dysfunction late after Kawasaki disease.
@ast
Endothelial dysfunction late after Kawasaki disease.
@en
Endothelial dysfunction late after Kawasaki disease.
@nl
P2093
P356
P1433
P1476
Endothelial dysfunction late after Kawasaki disease.
@en
P2093
Clarkson P
Deanfield JE
P304
P356
10.1161/01.CIR.94.9.2103
P407
P577
1996-11-01T00:00:00Z